3 FTSE 100 Shares To Avoid Market Madness: AstraZeneca plc, SSE PLC And G4S plc

Statistically, AstraZeneca plc (LON:AZN), SSE PLC (LON:SSE) and G4S plc (LON:GFS) have all avoided wild market swings. Are the shares worth picking up?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.


Pharmaceuticals like AstraZeneca (LSE: AZN) (NYSE: AZN.US) are frequently steady performers. That is because their sales are rarely influenced by wider economic conditions.

AstraZeneca uses the relative safety of its income stream to pay a large dividend. As such, the company is regarded as one of the best income stocks on the market today.

However, earnings at AstraZeneca have been falling in recent years. Analysts have expressed some concerns over the company’s ability to develop new drugs and treatments.

A 5% earnings fall is forecast for 2013, with a 6% dip expected in 2014.

That puts the shares on a 2014 price-to-earnings (P/E) ratio of 10.1, with an anticipated yield of 5.7%. That’s a significant valuation discount to the average FTSE 100 share.


Utilities have even better visibility of future sales than the pharmaceuticals. The result is that their shares tend to avoid market extremes.

A large, dependable dividend also helps.

In the last five years, SSE (LSE: SSE) has increased its payout every year at an average rate of 6.8%. A dividend of 87.6p is forecast for 2013, rising to 91.5p next year.

At today’s price, that’s a forecast yield of 5.4%, rising to 5.6% in 2014.

Earnings are expected to increase even faster. That puts the shares on a 2013 P/E of 14, falling to 13 next year.

The shares are 15% ahead this year, suggesting that any future rises may be limited.


Outsourcing contractor G4S (LSE: GFS) is one of the most interesting opportunities in the FTSE 100 today.

Before the company’s failure to provide security guards for the London Olympics, G4S stock was loved by the investment community. After years of huge growth, the shares were frequently rated at a substantial premium to the rest of the market.

The Olympic fiasco, a profit warning in May and now a potential over-billing scandal has seen the shares lose fans fast. Today, G4S shares are trading on a 2013 P/E of 10.5, with an expected yield of 4.3%.

The G4S brand has taken a battering in the last year but if the company can win back the market’s love, then I expect the shares to rise significantly.

One of the world’s top investors has recently been backing G4S and AstraZeneca. Professional fund manager Neil Woodford has been beating the market for decades with his dividend income fund. For more of Mr Woodford’s top picks, get the free Motley Fool report “8 Shares Held By Britain’s Super Investor”. This report is totally free. Click here to get your copy today.

> David does not own shares in any of the companies mentioned.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

3 top FTSE 100 value shares I’d buy before August!

These FTSE 100 heavyweight shares have considerable long-term potential. And at current prices, I think they are too cheap to…

Read more »

Investing Articles

Here’s why I’m selling my Lloyds shares to double down on this FTSE 100 stock

Our writer digs into why he prefers HSBC over Lloyds shares right now, despite both performing really strongly in recent…

Read more »

Investing Articles

I’d invest £12,500 in this 1 stock to bag £1K of passive income!

Building a passive income stream through dividends is one of this writer’s biggest ambitions. Here’s how one stock could help.

Read more »

Investing Articles

3 cheap stocks to consider buying for the AI revolution

Investors looking for AI stocks to buy might be worried about high valuations amid current market euphoria, but these three…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Earnings up 20%! But this UK small-cap stock may just be getting started

Are we about to see enduring growth from this UK small-cap business with a rising stock price ahead over the…

Read more »

Investing Articles

1 FTSE 250 stock I’d give a wide berth… for now

One of the worst performers on the FTSE 250 index is a stock that Sumayya Mansoor has decided she won’t…

Read more »

Investing Articles

The FTSE 250 is brimming with potential, especially in stocks like this one

The main Footsie index gets all the attention but its little brother, the FTSE 250, is full of growth potential.…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

What on earth happened to the Premier African Minerals (LSE:PREM) share price?

The Premier African Minerals (LSE:PREM) share price is down a whopping 85% in the last year, so what happened? Gordon…

Read more »